Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141116 |
TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2021-06-17 | 2021-10-21 | 141119 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141122 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141125 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141128 |
TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2021-06-24 | 2022-02-05 | 141457 |
TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2021-06-24 | 2021-07-09 | 141460 |
TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-24 | 2021-07-15 | 141463 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-06-24 | 2022-01-07 | 141466 |
CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-06-24 | 2021-07-09 | 141469 |
ZADITEN | 1MG | TABLET | Resolved | 2021-06-24 | 2021-07-29 | 141474 |
TEVA-PRAZOSIN | 5MG | TABLET | Resolved | 2021-06-24 | 2021-08-13 | 141477 |
TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-06-24 | 2022-04-28 | 141480 |
TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-06-24 | 2021-12-01 | 141483 |
TEVA-SULINDAC | 150MG | TABLET | Resolved | 2021-06-24 | 2021-07-15 | 141486 |
TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Resolved | 2021-06-24 | 2022-01-20 | 141489 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142172 |
TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2021-07-08 | 2023-09-22 | 142175 |
TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2021-07-08 | 2023-09-24 | 142178 |
TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142183 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |